- Home
- KNSA vs DAN Comparison
KNSA vs DAN Comparison
Compare KNSA & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | DAN |
|---|---|---|
| Founded | 2015 | 1904 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KNSA | DAN |
|---|---|---|
| Price | $55.11 | $29.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $60.86 | $40.60 |
| AVG Volume (30 Days) | 492.0K | ★ 1.4M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | 225.00 | ★ 264.10 |
| EPS | 0.27 | ★ 9.89 |
| Revenue | $677,564,000.00 | ★ $7,500,000,000.00 |
| Revenue This Year | $37.48 | $1.89 |
| Revenue Next Year | $17.87 | $4.59 |
| P/E Ratio | $204.43 | ★ $2.93 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | $15.31 |
| 52 Week High | $59.87 | $39.56 |
Technical Indicators
Market Signals| Indicator | KNSA | DAN |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 34.59 |
| Support Level | $40.67 | $28.30 |
| Resistance Level | $59.87 | $31.73 |
| Average True Range (ATR) | 1.83 | 1.85 |
| MACD | 0.59 | -0.76 |
| Stochastic Oscillator | 91.10 | 13.55 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About DAN Dana Incorporated
Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.